[A study of bromazepam in hospital practice (author's transl)].
The effectiveness of bromazepam was evaluated in 32 hospital out-patients suffering from reactional depression or anxiety-depression syndrome. Dosages ranged from 6 to 9 mg/24 hours in 3 divided doses. Results were assessed by means of a battery of tests (Hamilton's scale, self-evaluation scores of Hopkins, Pull-Guelfi's scale, Bond's psychometric tests) performed on days 0, 14 and 18. Good results were obtained in two-thirds of the patients, and these continued treatment for more than one month.
D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy*; D001960:Bromazepam / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006760:Hospitalization; D006801:Humans; D007046:Hysteria / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy
D014151:Anti-Anxiety Agents; D001960:Bromazepam
Etude du bromazépam en clientèle hospitalière.